Category: Events

A highly positive & encouraging summit for the FineHeart team. Our booth was visited by many participants and we had promising discussions with many cardiologists, heart surgeons, as well as in scientific meetings. Our attendance was highlighted by a presentation by Stephane Garrigue, CSO, at the “New Developments” session. All the world’s leading cardiologists and heart medtech companies were there.

FineHeart one of the winners of the 2022 NA20 Bordeaux French tech innovation award

We were among the few companies selected by the European Innovation Council’s EIC Accelerator program that aims to help the most promising startups and SMEs to deploy disruptive innovations on the market. This takes the form first of a grant for €2.5 million.
This funding is expected to be followed by an equity investment by the EIC Fund of up to €15 million in the company’s Series C financing round.
This program, which aims to act as a catalyst to attract private investors to high-potential companies, is part of the European Union’s €95 billion Horizon Europe framework program for research and innovation. FineHeart is one of 13 French companies, and the only Medtech, to have been awarded a grant at the latest session of this competition which rewarded 75 European companies out of more than 1000 candidates.

Francis Pagani, head of the Department of Cardiac Assist at the University of Michigan Ann Arbor, and a member of FineHeart’s Scientific Advisory Board, gave a talk at the Brano Heart Failure Forum in Trieste, Italy in early September. He presented the pre-clinical results of the ICOMS FLOWMAKER® in front of a hundred world specialists in cardiac assistance.

Stephane Garrigue participated in April in a conference organized by the town of Pessac under the theme «New Biomedical Technologies for Health». This event coincided with the visit of the “Bus du Coeur” (Heart Bus) set up by the Association “Agir Pour le Coeur des Femmes” (“Acting for the Hearts of Women Association”) to give women the chance to have free cardiovascular screening. After Cannes, the operation in Pessac screened the largest number of patients (about 250 women). Agir pour le Coeur des Femmes launched the “Heart Bus” in 2021 as a mobile information, awareness and prevention initiative for cardiovascular disease in women across France.

FineHeart received the “Grand Prix Check Up Santé BFM in the “Medical Device” category. (BFM is a major French business TV network and this award represents a great achievement)
The jury rewarded the audacity and vision of Dr. S. Garrigue MD, for the concept of the ICOMS FLOWMAKER®, by highlighting this “small electric bicycle of the heart” which will allow patients to lead a normal existence again in spite of their incapacitating disease. They will be able to have a shower or a bath, have an intimate life, as well as no longer needing dressings, antibiotics, nor nursing care, and to avoid the complications related to the external electric supply to the batteries.

FineHeart attended the European Mechanical Circulatory Support Summit (EUMS), held in Paris from September 3 to 6. A leading event in the field of cardiology, this congress brought together hundreds of players in the healthcare sector.
An exhibition stand was set up to enable visitors to discover the innovative FLOWMAKER® technology, and its future applications for patients suffering from severe heart failure. The highlight of the event was Professor Laurent Barandon’s presentation of the latest advances in the FLOWMAKER® to an audience of experts. 

FineHeart was delighted to host its ICOMS FLOWMAKER® webcast on June 25th 2020 with leading US cardiac KOLs Professors Mandeep Mehra and Frank Pagani.

Watch the webinar replay on : https://channel.royalcast.com/webcast/fineheart/20200625_1/

Attended by close to 100 participants, FineHeart showed the potential of ICOMS FLOWMAKER®, the first intraventricular pump, to save lives from heart failure.  Being only 18 months away from First In Human trials, ICOMS FLOWMAKER® respects the natural heart beats, has an easy implantation procedure and will bring a higher quality of life to patients.

KOLs validate the large unmet medical need in Heart Failure

We have clearly established that there is a ten-fold gap between the population that can be served versus the population currently being served.

Pr. Mandeep Mehra

And are positioning the ICOMS FLOWMAKER® as the next disruption:

 We see (the ICOMS FLOWMAKER®) as potentially a very very important disruption in the field moving forward.

Pr. Mandeep Mehra